Bridgefront Capital’s Arcellx ACLX Stock Holding History

Bridgefront Capital’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,641	Closed	-$256K	–	506
2024 Q2	$256K	Buy	+4,641	New	+$252K	0.11%	342

Other funds holding ACLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Bridgefront Capital's ACLX Position: Q3 2024 in Review

Bridgefront Capital sold out of Arcellx (ACLX) in Q3 2024, closing a stake of 4,641 shares — an estimated $256K sold.

Bridgefront Capital first reported a position in ACLX in Q2 2024 and held it in 1 quarter. The position peaked at $256K in Q2 2024. 186 funds tracked by Wall St. Rank hold ACLX as of Q3 2024.

Bridgefront Capital reported no remaining Arcellx position as of Q3 2024 after selling out during the quarter.
Bridgefront Capital sold 4,641 Arcellx shares in Q3 2024, an estimated $256K.
Bridgefront Capital first reported a position in Arcellx in Q2 2024 and held it in 1 quarter.
Bridgefront Capital's Arcellx position peaked at $256K in Q2 2024.
186 funds tracked by Wall St. Rank held Arcellx as of Q3 2024.

Based on Bridgefront Capital's 13F filing for Q3 2024, filed 14 Nov 2024.